EUVIMEDEUVIMED entdecken
Crossref

Ferrocenoyl-substituted quinolinone and coumarin as organometallic inhibitors of SARS-CoV-2 3CLpro main protease

Dominic Graf iD, Nikolas Farn, Jonas Klopf, Mahniya Hojjati, Ulrich Schatzschneider iD

Metallomics · 2023

DOI: 10.1093/mtomcs/mfad023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metallomics, 2023. Verfasst von Dominic Graf und 4 weiteren Autor:innen. Beteiligte Einrichtung: I nstitut für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 3-chymotrypsin-like protease 3CLpro from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a potential target for antiviral drug development. In this work, three organometallic ferrocene-modified quinolinones and coumarins were compared to their benzoic acid ester analogues with regard to inhibition of 3CLpro using an HPLC-based assay with a 15mer model peptide as the substrate. In contrast to FRET-based assays, this allows direct identification of interference of buffer constituents with the inhibitors, as demonstrated by the complete abolishment of ebselen inhibitory activity in the presence of dithiothreitol as a redox protectant. The presence of the organometallic ferrocene moiety significantly increased the stability of the title compounds towards hydrolysis. Among the studied compounds, 4-ferrocenyloxy-1-methyl-quinol-2-one was identified as the most stable and potent inhibitor candidate. IC50 values determined for ebselen and this sandwich complex compound are (0.40 ± 0.07) and (2.32 ± 0.21) μM, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansMetallocenesProtease InhibitorsCysteine EndopeptidasesCoumarinsMolecular Docking SimulationOrganoselenium CompoundsIsoindolesFerrous Compounds

Stichwörter der Autor:innen

3CLproSARS-CoV-2bioorganometallicscoumarinquinolinoneserine protease inhibitors

Substanzen

MetallocenesProtease InhibitorsCysteine EndopeptidasesCoumarinsebselenOrganoselenium CompoundsIsoindolesferroceneFerrous Compounds

Autor:innen und Institutionen

  • I nstitut für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany.
  • Institut für Anorganische Chemie, Julius-Maximilians-Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany.

ORCID-Profile: Dominic Graf, Ulrich Schatzschneider

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Graf, D., Farn, N., Klopf, J., Hojjati, M., & Schatzschneider, U. (2023). Ferrocenoyl-substituted quinolinone and coumarin as organometallic inhibitors of SARS-CoV-2 3CLpro main protease. Metallomics. https://doi.org/10.1093/mtomcs/mfad023

Vancouver

Graf D, Farn N, Klopf J, Hojjati M, Schatzschneider U. Ferrocenoyl-substituted quinolinone and coumarin as organometallic inhibitors of SARS-CoV-2 3CLpro main protease. Metallomics. 2023. doi:10.1093/mtomcs/mfad023

BibTeX
@article{Graf2023,
  author = {Graf, Dominic and Farn, Nikolas and Klopf, Jonas and Hojjati, Mahniya and Schatzschneider, Ulrich},
  title = {Ferrocenoyl-substituted quinolinone and coumarin as organometallic inhibitors of SARS-CoV-2 3CLpro main protease},
  journal = {Metallomics},
  year = {2023},
  doi = {10.1093/mtomcs/mfad023}
}
Kostenlos starten →